GTS Securities’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-50,800
Closed -$5.61M 1675
2024
Q3
$5.61M Buy
50,800
+3,200
+7% +$335K 0.01% 821
2024
Q2
$4.68M Sell
47,600
-9,100
-16% -$927K 0.01% 897
2024
Q1
$6.34M Buy
56,700
+17,100
+43% +$1.85M 0.01% 715
2023
Q4
$3.99M Sell
39,600
-64,100
-62% -$6.36M 0.01% 1157
2023
Q3
$9M Buy
+103,700
New +$9.37M 0.02% 642

Other funds holding CAH

GTS Securities's CAH Position: Q2 2026 in Review

GTS Securities sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 1,013 shares — an estimated $214K sold.

GTS Securities first reported a position in CAH in Q2 2023 and held it in 9 quarters. The position peaked at $2.47M in Q3 2023. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • GTS Securities reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • GTS Securities sold 1,013 Cardinal Health shares in Q2 2026, an estimated $214K.
  • GTS Securities first reported a position in Cardinal Health in Q2 2023 and held it in 9 quarters.
  • GTS Securities's Cardinal Health position peaked at $2.47M in Q3 2023.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.